Acurian Saves More than Four Months of Enrollment Time for Phase III Atopic Dermatitis Study

Dermatology

Atopic Dermatitis

This sponsor had blockbuster expectations for its compound in the treatment of moderate-to-severe atopic dermatitis when it began its Phase III study

Read More »